Johnson & Johnson reported Q2 2026 sales of US$25.3bn, up 6.6%, and raised its full-year guidance to US$101.1b…

Intuitive Surgical revealed a five-layer AI framework for its surgical platforms and demonstrated a live real-…

Walid Mehanna, chief data and A.I

Researchers used Google's AlphaFold AI to identify which parts of Cas9 proteins enable off-target DNA edits in…

Researchers used Google's AlphaFold AI to identify which parts of the Cas9 protein (used in CRISPR gene editin…

Innovaccer, a healthcare data platform founded by Abhinav Shashank, crossed $200 million(約320億円) in annual rec…

Johnson & Johnson's Polyphonic AI Fund for Surgery QuickFire Challenge selected awardees developing AI tools f…

The SPDR S&P Biotech ETF (XBI) has gained 25% this year and nearly 80% over the past 12 months, hitting its hi…

OpenAI is rolling out 'Health in ChatGPT' to U.S

OpenAI is rolling out ChatGPT Health to everyone in the US on Thursday, allowing users to connect medical reco…

OpenAI made ChatGPT Health available to all U.S.-based users over 18 across all subscription tiers (free, Go…

AstraZeneca and other pharmaceutical companies are embedding AI into every stage of biologic drug development—…

A Pfizer scientist received the Select Science Award for Video of the Year for work on oncology research and i…

Medtronic is launching an AI compute platform for operating rooms

Xaira Therapeutics, led by Chief Discovery Officer Ci Chu and Chief AI Scientist Bo Wang, built X-Cell, an AI…

AI systems are being deployed in healthcare to automate clinical documentation, information review, and admini…

Bristol Myers Squibb announced deployment of its second NVIDIA DGX SuperPOD, built on eight DGX Vera Rubin NVL…

Bristol Myers Squibb announced an expansion of its compute infrastructure through deployment of an Nvidia DGX…

Merck is intensifying its push into AI semiconductor materials as its Level Up project approaches completion

Merck is accelerating its push into AI semiconductor materials as it nears completion of Level Up, moving beyo…

Illumina announced that its Billion Cell Atlas alliance—launched in January 2026 with AstraZeneca, Merck, and…

A test of 16 AI models on 200 X-ray cases showed human radiologists scored 988.7 out of 2,000 points on a metr…

Three healthcare companies stand out for combining AI capabilities with scale: Pfizer ($143.3b market cap, ~US…

Thermo Fisher Scientific completed an $8.875 billion(約1.4兆円) cash acquisition of Clario Holdings, a clinical t…

The Trump administration's Centers for Medicare and Medicaid Services launched WISeR (Wasteful and Inappropria…

Scientists are adopting AI and robotics to replace human-led hypotheses in biological research with automated…

CVS Health is deploying artificial intelligence and technology solutions to address rising medication costs an…

Illumina announced three new members for its Billion Cell Atlas alliance, including AI-native drug developer F…

Johnson & Johnson reported second-quarter 2026 worldwide sales of $25.3 billion(約4兆円), up 5.6% operationally…

ExaWizards and ExaMD presented findings from a wearable device study on breast cancer patients at the American…

Lila Sciences is operating an automated laboratory—a warehouse of AI-guided robotics and instruments running e…

MindWalk Holdings Corp. (NASDAQ: HYFT), an Austin-based AI drug-discovery company, was added to the Russell 30…

Miles Wang, an OpenAI researcher, is leaving to launch a startup focused on AI models for drug discovery

Amgen and leading academic institutions held a roundtable conversation (Meeting the Moment) exploring how AI i…

Insilico Medicine initiated a Phase III clinical trial for Rentosertib, an oral small-molecule inhibitor targe…

Isomorphic Labs raised $2.1 billion(約3400億円) in May led by Thrive Capital and secured major partnerships with…

Five minutes each morning. That's the whole AI news habit.
The day's essentials from 200+ sources, delivered to Email, LINE, or Slack. Free, always.
30,000+ monthly readersAnthropic announced it is launching its own drug discovery programs targeting neglected diseases that traditio…

Genesis Molecular AI's PEARL model demonstrated on the OpenBind benchmark that it can accurately predict how s…

Meta researchers released Brain2Qwerty v2, which reconstructs typed sentences from brain signals measured outs…

MindWalk Holdings (NASDAQ: HYFT) announced the filing of European patent application EP26187897.9, which cover…

Eli Lilly led a $100 million(約160億円) stock offering in Absci, an AI drug company, investing $40 million(約64億円)…

PorMedTec, a startup spun out of Meiji University, announced it will conduct clinical trials transplanting pig…

A live podcast recording at the Great Exhibition Road Festival in London brought together three leading UK aca…

AWS published a blog post demonstrating how to build multi-tenant AI applications using Amazon Bedrock AgentCo…

Thermo Fisher announced new investments across three areas at BIO International 2026

Jacobi–IDE compiles and runs a suite of 12 physics tests on Abaqus subroutines (specialist engineering simulat…

Eli Lilly and Twist Bioscience are using AI in drug development in different ways

Pramaana Labs announced $27 million(約43億円) in seed funding led by Khosla Ventures, with participation from Acc…

Google published research in Nature showing that AMIE, its medical AI system, can now manage ongoing health co…

AWS Strands Evals SDK now includes detector functions that automatically scan AI agent execution traces to ide…

Radical Numerics emerged from stealth with a $50 million(約80億円) seed round led by Emergence Capital, with part…

Researchers compared two specialized clinical AI tools—OpenEvidence and UpToDate Expert AI—against three front…

Eli Lilly has invested in Abridge, an AI-focused clinician documentation company whose platform is used across…

Abridge closed a $316 million(約510億円) Series E extension in April 2026 at a $5.3 billion(約8500億円) valuation

Nxera Pharma announced on 10 June 2026 that it has joined OpenFold, a non-profit AI research consortium that d…

Thermo Fisher Scientific unveiled three new Orbitrap mass spectrometry platforms—Orbitrap Tribrid Apex MS, Orb…

Hoffman, co-founder of LinkedIn (acquired by Microsoft for $26.2 billion in 2016), is leaving Microsoft's boar…

Compal Electronics demonstrated CGA-QX Docking, a production-ready platform developed with NVIDIA and academic…

Absci positions itself as a 'data-first generative AI drug creation company' that uses AI to design potential…

At Google I/O, DeepMind CEO Demis Hassabis stated that the company hopes to 'reimagine the drug discovery proc…

Shyld AI, founded by brothers Mohammad and Morteza Noshad, raised a $13.4 million seed round led by Aulis Capi…

Isomorphic Labs, led by Alphabet co-founder Demis Hassabis, raised $2.1 billion in a Series B round led by Thr…

The market valuation is USD 1.86 billion in 2025 and is projected to reach USD 8.85 billion by 2030, driven by…

American companies drive 55% of global R&D in biopharmaceuticals and produce more new medicines than any other…

NVIDIA entered a collaboration with Simulations Plus to apply GPU acceleration and AI-assisted workflows to dr…

Antibiotic resistance causes more than a million global deaths annually and contributes to nearly 5 million mo…

OpenAI released ChatGPT for Clinicians, a free AI tool built specifically for medical professionals

95% of cancer treatments fail during clinical trials, representing a massive inefficiency in drug development

Market valued at $3.36 trillion through 2040, driven by major players including Google DeepMind, IBM Watson He…

IQVIA Holdings has unveiled IQVIA.ai, a proprietary artificial intelligence platform developed in partnership…

QU-NLP team applies two-stage Quantised Low-Rank Adaptation (QLoRA) to Qwen3-4B loaded in 4-bit NF4 quantisati…

Study reveals supervised fine-tuning (SFT) functions as a special case of policy gradient optimization with sp…

Get curated AI news from 200+ sources delivered daily to your inbox. Free to use.
30,000+ monthly readers
Get Started FreeFree · takes 30 seconds · unsubscribe anytime